Glutamatergic Approaches to the Treatment of Cognitive and Behavioural Symptoms of Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1660-2862|5|3-4|241-243

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.5, Iss.3-4, 2008-03, pp. : 241-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinoids as a Perspective in Treatment of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-03 ,pp. : 190-192

Karger

Access to resources Recommend Favorite

Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment

By  

Neurodegenerative Diseases, Vol. 4, Iss. 6, 2007-10 ,pp. : 406-412

Karger

Access to resources Recommend Favorite

Cognitive recovery and restoration of cell proliferation in the dentate gyrus in the 5XFAD transgenic mice model of Alzheimer’s disease following 2-hydroxy-DHA treatment

By Fiol-deRoque Maria   Gutierrez-Lanza Raquel   Terés Silvia   Torres Manuel   Barceló Pere   Rial Rubén   Verkhratsky Alexei   Escribá Pablo   Busquets Xavier   Rodríguez José  

Biogerontology, Vol. 14, Iss. 6, 2013-12 ,pp. : 763-775

Springer Publishing Company

Access to resources Recommend Favorite

Alzheimer’s as a metabolic disease

By Demetrius Lloyd   Driver Jane  

Biogerontology, Vol. 14, Iss. 6, 2013-12 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Retromers in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-03 ,pp. : 116-121

Karger

Access to resources Recommend Favorite